active
ACTIVE SINCE: 2017

Improving access to our anticancer product in India

Collaborating with local partners to improve access to our anticancer product in India.
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Local NGOs 1
Objectives
  • Increase the number of patients able to access our anticancer product in India.

What are the health needs and challenges?

With changes in lifestyle-related behavior, the incidence rate of prostate cancer is constantly and rapidly increasing in India. Some cancer projection data show that the number of cases will double by 2020 (as compared to 2012).

In India, most patients have to pay the full cost of purchasing prescription.

Partnership activities and how they address needs and challenges

Astellas is introducing a new program structured according to patients’ income levels to improve patients’ access to our anticancer product in India, in collaboration with local partners. It is believed that this new program will increase the number of patients able to access our product in India. Astellas recognizes that the affordability of medicines is one aspect impacting patients’ Access to Health. We will continue exploring various solutions which improve patients’ access to our products.

Quote
"Astellas will continue exploring various solutions which improve patients access to our products."
Geographic Reach
  • South-East Asia
See Where
Disease Area
  • Non-communicable diseases
See Disease Areas
Partner organizations
Local NGOs
Local
associations

One partner conducts a financial assessment of patients (to assess eligibility) and the other partner provides our anticancer product to patients based on the assessment.